Pharmacogenomics of dyslipidaemia drugs in Portugal


Poster presented at the 88th European Atherosclerosis Society Congress. Virtual congress on 4-7 October 2020


J. Chora, M. Bourbon
Atherosclerosis, vol. 315, 2020 Dec 1, pp. e275


Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Chora, J., & Bourbon, M. (2020). Pharmacogenomics of dyslipidaemia drugs in Portugal. In Atherosclerosis (Vol. 315, p. e275). https://doi.org/10.1016/j.atherosclerosis.2020.10.867


Chicago/Turabian   Click to copy
Chora, J., and M. Bourbon. “Pharmacogenomics of Dyslipidaemia Drugs in Portugal.” In Atherosclerosis, 315:e275, 2020.


MLA   Click to copy
Chora, J., and M. Bourbon. “Pharmacogenomics of Dyslipidaemia Drugs in Portugal.” Atherosclerosis, vol. 315, 2020, p. e275, doi:10.1016/j.atherosclerosis.2020.10.867.


BibTeX   Click to copy

@conference{j2020a,
  title = {Pharmacogenomics of dyslipidaemia drugs in Portugal},
  year = {2020},
  month = dec,
  day = {1},
  journal = {Atherosclerosis},
  pages = {e275},
  volume = {315},
  doi = {10.1016/j.atherosclerosis.2020.10.867},
  author = {Chora, J. and Bourbon, M.},
  month_numeric = {12}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in